UPDATE : Monday, December 10, 2018
상단여백
Chong Kun Dang gets license for generic immunosuppressant by So Jae-hyeon 2018-08-03 15:38
Korean drugmakers rush to establish US subsidiaries by So Jae-hyeon 2018-08-03 14:40
Pharmacists, convenience store owners in dispute over OTC drugs by So Jae-hyeon 2018-08-02 15:32
Daewoong Bio’s dementia drug hits 3-digit sales growth by So Jae-hyeon 2018-08-01 15:50
Sales of osteoporosis drugs falter, combo therapies survive by So Jae-hyeon 2018-07-31 15:37
라인
SillaJen, Medytox one step closer to entering China by So Jae-hyeon 2018-07-31 13:09
[News scene] Why did pharmacists take to street in hottest weather? by So Jae-hyeon 2018-07-30 14:34
Sales of impotence drugs slide by So Jae-hyeon 2018-07-26 14:12
Antidiabetic drug Zemiglo up, cancer drug Supect down in H1 sales by So Jae-hyeon 2018-07-24 11:11
Stock declines, negative rumors haunt biotech industry by So Jae-hyeon 2018-07-23 16:39
라인
Latecomer Lixiana’s chase after Eliquis gets faster by So Jae-hyeon 2018-07-20 12:01
Bifido wins patent for microbiome-based treatment in US by So Jae-hyeon 2018-07-19 15:42
Kolon Life Science inks deal to sell Invossa to China by So Jae-hyeon 2018-07-18 16:46
Dong-A ST’s Jublia dominates athlete’s foot drugs by So Jae-hyeon 2018-07-18 11:50
Korean eye drops selling well overseas by So Jae-hyeon 2018-07-17 11:36
라인
When will Seoul update drug review system for cell therapies? by So Jae-hyeon 2018-07-16 12:36
Edarbi, Saxenda prescribed in major hospitals by So Jae-hyeon 2018-07-11 15:42
Local drug makers strive to conquer neurological diseases by So Jae-hyeon 2018-07-09 12:09
Platform technologies key to developing new drugs by So Jae-hyeon 2018-07-03 16:12
SillaJen to develop biomarker for JX-970 by So Jae-hyeon 2018-07-03 14:19
여백
여백
여백
Back to Top